Addition of aliskiren to Angiotensin receptor blocker improves ambulatory blood pressure profile and cardiorenal function better than addition of benazepril in chronic kidney disease.

Int J Mol Sci · 2013 · PMC3759864 · PMID 23887656

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although there was a decreased nighttime systolic BP in the aliskiren add-on group compared with the benazepril add-on therapy, the changes in nighttime systolic BP between the aliskiren add-on group and the benazepril add-on group did not reach statistical significance with this number of patients.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.